What's breaking now, across thousands of outlets.
As with many of the most feared neurological conditions, Huntington’s disease has proven to be a minefield for drug developers. Promising biomarker data didn’t translate into clinical benefits in Roche’s recent study ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
In the deepest region of the Earth's mantle, just above the core, much of the material consists of crystals of magnesium oxide.
[International] : The foreign ministry says DNA tests have failed to identify remains recovered from the Chosei Coal Mine, a long-abandoned mine in Japan where 183 people, including 136 Koreans, were…
What exactly is a mathematical proof? Columnist Jacob Aron breaks down how mathematicians plot a course to answer open questions, and how finding several solutions to the same problem is an important…
Identifying individual animals in the wild has long meant tagging, branding or clipping. For amphibians, the standard approach has often been toe-clipping, a procedure that can affect survival…
New research reveals that faster growth rates in Honeycrisp apples increase both the incidence and severity of the "bitter pit" disorder, which is responsible for large-scale fruit yield losses and…
